Floatz logo

Folic Acid

Coronary Disease

Fuling Central Hospital of Chongqing CitySmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Coronary Disease cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Ezetimibe
Canadian Collaborative Research Network
Phase 4BBB
Rivaroxaban
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BBB
SIMVASTATIN
University of Washington
Phase 4BBB
Ranolazine
OBS Pakistan
Phase 4BBB

View all 50 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →